CD68 and meningioma: Interestingly, the authors reported higher PD-L1 expression in CD68-negative cells (likely tumor cells) in WHO°2 and °3 tumors and described further high PD-L1+/CD68- staining as an independent prognostic marker for poor overall survival in meningioma patients [30,42].